Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05017246 · ClinicalTrials.gov registry record · Phase 2

Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy

A Phase 2 study, sponsored by Washington University School of Medicine.

Terminated
Registry status
Phase 2
Development phase
110
Enrollment target

NCT05017246: Clinical Trial Phase 2 study, sponsored by Washington University School of Medicine.

NCT05017246 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 110 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05017246, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
Phase 2
Development phase
110 participants
Enrollment target

Study Summary

To determine if opioid consumption postoperatively among patients undergoing non-emergent laparotomy by the gynecologic oncology service who receive intrathecal morphine with intraoperative lidocaine (IML) infusion are lower than patients who have epidural anesthesia with PCA (EPCA).

Interventions

  • DRUG Bupivacaine
  • DRUG Lidocaine
  • DRUG Morphine

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2022-01-18
Est. Completion 2024-08-29
Phase Phase 2

Why NCT05017246 stopped before completion

NCT05017246 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% lower).

The record links to 0 conditions, and to 3 interventions - of which Bupivacaine is the first listed.

NCT05017246 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05017246 about?

NCT05017246 is a clinical study titled "Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy". To determine if opioid consumption postoperatively among patients undergoing non-emergent laparotomy by the gynecologic oncology service who receive intrathecal morphine with intraoperative lidocaine (IML) infusion are lower than patients who have epidural anesthesia with PCA (EPCA).

What is the current status of trial NCT05017246?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2022-01-18. Estimated completion is 2024-08-29.

What interventions are being tested in trial NCT05017246?

The interventions under investigation include: Bupivacaine (DRUG), Lidocaine (DRUG), Morphine (DRUG).

Who is sponsoring clinical trial NCT05017246?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05017246's enrollment target sits among peer trials

110 632nd of 2000 higher than 1,361 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05017246, the US trial registry maintained by the National Library of Medicine. NCT05017246 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.